{"id":"https://openalex.org/W2053936595","doi":"https://doi.org/10.1158/1538-7445.am2012-4823","title":"Abstract 4823: Copy number gain and increased expression of BLM and FANCI is associated with sensitivity to genotoxic chemotherapy in triple negative breast and serous ovarian cancer","display_name":"Abstract 4823: Copy number gain and increased expression of BLM and FANCI is associated with sensitivity to genotoxic chemotherapy in triple negative breast and serous ovarian cancer","publication_year":2012,"publication_date":"2012-04-01","ids":{"openalex":"https://openalex.org/W2053936595","doi":"https://doi.org/10.1158/1538-7445.am2012-4823","mag":"2053936595"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2012-4823","doi":"https://doi.org/10.1158/1538-7445.am2012-4823","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2012-4823","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5080932242","display_name":"Nicolai J. Birkbak","orcid":"https://orcid.org/0000-0003-1613-9587","observed_orcids":["https://orcid.org/0000-0003-1613-9587"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nicolai J. Birkbak","raw_affiliation_strings":["1Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101676868","display_name":"Yang Li","orcid":"https://orcid.org/0000-0002-4308-5118","observed_orcids":["https://orcid.org/0000-0002-4308-5118"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yang Li","raw_affiliation_strings":["1Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009167354","display_name":"Zhigang C. Wang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zhigang C. Wang","raw_affiliation_strings":["1Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030179640","display_name":"Daniel P. Silver","orcid":"https://orcid.org/0000-0003-3771-806X","observed_orcids":["https://orcid.org/0000-0003-3771-806X"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel P. Silver","raw_affiliation_strings":["1Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109908699","display_name":"James Dirk Iglehart","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James D. Iglehart","raw_affiliation_strings":["1Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005206482","display_name":"Judy Ellen Garber","orcid":"https://orcid.org/0000-0001-9449-3982","observed_orcids":["https://orcid.org/0000-0001-9449-3982"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Judy E. Garber","raw_affiliation_strings":["1Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021830443","display_name":"Zolt\u00e1n Sz\u00e1ll\u00e1si","orcid":"https://orcid.org/0000-0001-5395-7509","observed_orcids":["https://orcid.org/0000-0001-5395-7509"]},"institutions":[{"id":"https://openalex.org/I96673099","display_name":"Technical University of Denmark","ror":"https://ror.org/04qtj9h94","country_code":"DK","type":"education","lineage":["https://openalex.org/I96673099"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Zoltan Szallasi","raw_affiliation_strings":["2Technical University of Denmark, Copenhagen, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Technical University of Denmark, Copenhagen, Denmark","institution_ids":["https://openalex.org/I96673099"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5015821699","display_name":"Andrea L. Richardson","orcid":"https://orcid.org/0000-0001-5221-1094","observed_orcids":["https://orcid.org/0000-0001-5221-1094"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrea L. Richardson","raw_affiliation_strings":["1Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"72","issue":"8_Supplement","first_page":"4823","last_page":"4823"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","score":0.4514000117778778,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","score":0.4514000117778778,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.4088999927043915,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10123","display_name":"DNA Repair Mechanisms","score":0.05009999871253967,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/blm","display_name":"BLM","score":0.7829999923706055},{"id":"https://openalex.org/keywords/fanci","display_name":"FANCI","score":0.9990000128746033},{"id":"https://openalex.org/keywords/copy-number-gain","display_name":"copy number gain","score":0.8619999885559082},{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.7680000066757202},{"id":"https://openalex.org/keywords/serous-ovarian-cancer","display_name":"serous ovarian cancer","score":0.9850000143051147},{"id":"https://openalex.org/keywords/cisplatin-sensitivity","display_name":"cisplatin sensitivity","score":0.7820000052452087},{"id":"https://openalex.org/keywords/carboplatin","display_name":"carboplatin","score":0.7699999809265137},{"id":"https://openalex.org/keywords/genotoxic-chemotherapy","display_name":"genotoxic chemotherapy","score":0.7110000252723694},{"id":"https://openalex.org/keywords/dna-repair","display_name":"DNA repair","score":0.7129999995231628},{"id":"https://openalex.org/keywords/epirubicin","display_name":"epirubicin","score":0.7670000195503235},{"id":"https://openalex.org/keywords/taxanes","display_name":"taxanes","score":0.8840000033378601},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.6430000066757202},{"id":"https://openalex.org/keywords/platinum-response","display_name":"platinum response","score":0.42899999022483826},{"id":"https://openalex.org/keywords/anthracycline-response","display_name":"anthracycline response","score":0.7889999747276306},{"id":"https://openalex.org/keywords/neoadjuvant-chemotherapy","display_name":"neoadjuvant chemotherapy","score":0.746999979019165}],"concepts":[{"id":"https://openalex.org/C2781451048","wikidata":"https://www.wikidata.org/wiki/Q415588","display_name":"Carboplatin","level":4,"score":0.7515050172805786},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.7253437638282776},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.6157146692276001},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6019238233566284},{"id":"https://openalex.org/C2780835546","wikidata":"https://www.wikidata.org/wiki/Q425122","display_name":"Epirubicin","level":4,"score":0.5861907005310059},{"id":"https://openalex.org/C2780110267","wikidata":"https://www.wikidata.org/wiki/Q7843332","display_name":"Triple-negative breast cancer","level":4,"score":0.5399015545845032},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5355206727981567},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.5304864048957825},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5293541550636292},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5050533413887024},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.48139500617980957},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4757554233074188},{"id":"https://openalex.org/C134935766","wikidata":"https://www.wikidata.org/wiki/Q210538","display_name":"DNA repair","level":3,"score":0.4710778295993805},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3058345913887024},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.21161451935768127},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.15581893920898438}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2012-4823","doi":"https://doi.org/10.1158/1538-7445.am2012-4823","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2012-4823","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2022622248","https://openalex.org/W2792164419","https://openalex.org/W2168409298","https://openalex.org/W7134900506","https://openalex.org/W2049494585","https://openalex.org/W2478511566","https://openalex.org/W1973736220","https://openalex.org/W2057319359","https://openalex.org/W1966220214","https://openalex.org/W2096055355"],"abstract_inverted_index":{"Abstract":[0],"Introduction.":[1],"Genotoxic":[2],"chemotherapy":[3,90,230],"such":[4,345],"as":[5,346],"platinum":[6,143,180],"salts":[7],"and":[8,13,29,82,156,173,195,209,223,251,265,289,314,348,353],"anthracyclines":[9,347],"induce":[10],"DNA":[11,49,76,216,322],"damage":[12],"are":[14,316,350],"among":[15],"the":[16,97,151,158,199,256,261,293,338,432,437],"most":[17],"widely":[18],"used":[19],"anti-cancer":[20],"agents.":[21],"Previous":[22],"molecular":[23],"studies":[24],"have":[25],"shown":[26],"that":[27,103,309,337,341,354],"BRCA1-associated":[28],"sporadic":[30],"triple-negative":[31],"breast":[32],"cancers":[33,43,254],"(TNBC)":[34],"carry":[35],"high":[36,310],"levels":[37],"of":[38,80,161,186,242,312,332,364,431,436],"genomic":[39,65],"abnormalities,":[40],"suggesting":[41],"these":[42],"may":[44,52,67],"share":[45],"similar":[46],"defects":[47],"in":[48,91,117,124,129,131,182,189,198,206,214,236,252],"repair,":[50],"which":[51],"make":[53],"them":[54],"particularly":[55],"sensitive":[56,207],"to":[57,71,211,275,292,300,321,329,343,360],"genotoxic":[58,229],"chemotherapy.":[59],"Results.":[60],"To":[61,134,219],"investigate":[62,220],"whether":[63],"specific":[64],"aberrations":[66],"affect":[68],"cancer":[69,164,298],"sensitivity":[70,274],"cisplatin,":[72],"we":[73,101,145,232],"generated":[74],"tumor":[75],"copy":[77,115],"number":[78,116],"profiles":[79],"21":[81],"24":[83],"TNBC":[84,153,290],"patients":[85],"who":[86],"received":[87],"pre-operative":[88],"cisplatin-based":[89],"two":[92],"separate":[93],"clinical":[94],"trials.":[95,133,371],"Using":[96],"GISTIC":[98],"algorithm":[99],"(1),":[100],"found":[102,174],"only":[104],"a":[105,170],"single":[106,301,365],"region":[107],"on":[108,138,369],"chromosome":[109],"15q26":[110,139,200],"showed":[111],"consistent":[112],"significant":[113],"differential":[114],"responders":[118,130],"versus":[119],"non-responders,":[120,125],"being":[121],"preferentially":[122,127],"lost":[123],"but":[126,325],"gained":[128],"both":[132,190,202],"see":[135],"if":[136,221],"genes":[137,176],"were":[140,225],"associated":[141,178,227,271,317],"with":[142,179,228,272,318,327],"sensitivity,":[144,231],"acquired":[146],"gene":[147],"expression":[148,205,235,267,288,311],"data":[149,307],"from":[150,157,238,255],"cisplatin":[152],"trial":[154,165],"(2),":[155],"carboplatin-only":[159],"arm":[160],"an":[162],"ovarian":[163,253,297],"(3).":[166],"We":[167],"then":[168],"performed":[169],"leave-one-out":[171],"analysis,":[172],"9":[175],"significantly":[177,270],"response":[181,291,299,320,328,367],"at":[183],"least":[184],"75%":[185],"all":[187],"rounds":[188],"cohorts.":[191],"These":[192,306],"included":[193],"BLM":[194,222,264,285,313],"FANCI":[196,224,266,287,315],"located":[197],"region,":[201],"showing":[203],"higher":[204],"tumors,":[208],"known":[210],"be":[212,358],"involved":[213],"related":[215],"repair":[217],"processes.":[218],"specifically":[226],"analyzed":[233],"their":[234],"TNBCs":[237],"three":[239],"neoadjuvant":[240],"trials":[241],"epirubicin":[243,262],"alone":[244],"or":[245,286,296],"taxane-containing":[246,294],"combination":[247],"therapy":[248],"(5,":[249],"6)":[250],"taxane-only":[257],"treatment":[258],"arm(3).":[259],"In":[260,277],"trial,":[263],"was":[268,280],"again":[269],"increased":[273],"therapy.":[276],"contrast,":[278],"there":[279],"no":[281],"association":[282],"between":[283],"either":[284],"regimen":[295],"agent":[302,366],"taxane":[303],"treatment.":[304],"Conclusions.":[305],"suggest":[308],"improved":[319],"damaging":[323],"agents,":[324],"not":[326,351],"other":[330],"types":[331],"chemotherapeutics.":[333],"Furthermore,":[334],"it":[335,355],"suggests":[336],"patient":[339],"subpopulations":[340],"respond":[342],"drugs":[344],"taxanes":[349],"overlapping,":[352],"will":[356],"therefore":[357],"difficult":[359],"robustly":[361],"identify":[362],"predictors":[363],"based":[368],"multi-drug":[370],"1.":[372],"Beroukhim":[373],"et":[374,386,395,402,409,417],"al.":[375,387,396,403,410,418],"Proc":[376],"Natl":[377],"Acad":[378],"Sci":[379],"U":[380],"S":[381],"A.":[382],"2007;104:20007-12.":[383],"2.":[384],"Silver":[385],"Cancer.":[388],"J":[389,411],"Clin":[390,412],"Oncol.":[391,413],"2010.":[392],"3.":[393],"Ahmed":[394],"Cancer":[397,420,441,452],"Cell.":[398],"2007;12:514-27.":[399],"4.":[400],"Li":[401],"Nat":[404],"Med.":[405],"2010;16:214-8.":[406],"5.":[407],"Hess":[408],"2006;24:4236-44.":[414],"6.":[415],"Popovici":[416],"Breast":[419],"Res.":[421],"2010;12:R5.":[422],"Citation":[423],"Format:":[424],"{Authors}.":[425],"{Abstract":[426],"title}":[427],"[abstract].":[428],"In:":[429],"Proceedings":[430],"103rd":[433],"Annual":[434],"Meeting":[435],"American":[438],"Association":[439],"for":[440],"Research;":[442],"2012":[443],"Mar":[444],"31-Apr":[445],"4;":[446],"Chicago,":[447],"IL.":[448],"Philadelphia":[449],"(PA):":[450],"AACR;":[451],"Res":[453],"2012;72(8":[454],"Suppl):Abstract":[455],"nr":[456],"4823.":[457],"doi:1538-7445.AM2012-4823":[458]},"counts_by_year":[],"updated_date":"2026-10-01T08:54:57.152042","created_date":"2016-06-24T00:00:00"}